GFAP-Cre transgenic mice from founder line 77.6 have Cre recombinase expression directed to astrocytes in the brain and spinal cord by the mouse glial fibrillary acidic protein promoter. These GFAP-Cre line 77.6 mice may be useful for studying astrocytes in the brain and spinal cord.
Michael V Sofroniew, University of California Los Angeles
Genetic Background | Generation |
---|---|
N15+pN3F3
|
Allele Type |
---|
Transgenic (Recombinase-expressing) |
Starting at:
$255.00 Domestic price for female 4-week |
333.51 Domestic price for breeder pair |
In 2014, The Jackson Laboratory imported correctly-expressing GFAP-Cre line 77.6 mice from Dr. Michael Sofroniew to establish Stock No. 024098. This replaces Stock No. 012887.
Mice hemizygous for the Gfap-cre transgene are viable and fertile, with a mouse glial fibrillary acidic protein (mGfap) promoter sequence directing expression of Cre recombinase. When GFAP-Cre line 77.6 mice are bred with mice containing a loxP-flanked sequence, Cre-mediated recombination is expected to result in deletion of the floxed sequences in the Cre recombinase-expressing tissues of the offspring.
Specifically, Cre recombinase activity (as defined by expression of a floxed-STOP reporter gene) is targeted to most astrocytes throughout healthy brain and spinal cord tissues, and to essentially all astrocytes following central nervous system (CNS) injury. Some germline expression is observed (see below).
These GFAP-Cre line 77.6 mice (Stock No. 024098) also have Cre recombinase activity in a subpopulation of adult neural stem cells in the subventricular zone. In contrast to GFAP-Cre line 73.12 (Stock No. 012886), GFAP-Cre line 77.6 mice are reported to have no Cre recombinase activity in postnatal or adult neural stem cells (or their progeny) from the hippocampus or other brain regions. As such, GFAP-Cre line 77.6 mice are particularly useful for selective targeting of astrocytes. Additionally, the donating investigator reports GFAP-Cre lines 73.12 and 77.6 have cre expression in the male germline, and suggests breeding GFAP-Cre females with floxed males for Cre-lox experiments.
Furthermore, Luo et al. 2020 Neuron 106:37 Table 1 shows germline recombination in offspring (F2) of Cre;floxed double mutant (F1) mice bred to floxed and/or wildtype mice. The authors also note that in general, the frequency of recombination in Cre;floxed double mutant germline cells appears to be considerably higher than in zygotes produced by breeding Cre mice to floxed mice.
This reports that GFAP-Cre line 77.6;floxed double mutant males bred to floxed females produced some offspring with germline deletion of the floxed allele [observed from several cohorts (including up to 100% in a few litters)]. As such, for Cre-lox experiments and to avoid/minimize germline deletion of the floxed allele, researchers may consider breeding GFAP-Cre line 77.6 females to floxed males.
If the recombinase activity pattern of this allele is further characterized by the Genetic Resource Science group at The Jackson Laboratory, such findings will be reported on the Mouse Genome Informatics (MGI) Allele Detail entry. This same information may also be found searching the MGI Recombinase Activity and MGI Gene Expression + Recombinase Activity Comparison Matrix.
The mGFAP-Cre transgene was designed by Dr. Michael V. Sofroniew (University of California, Los Angeles) with the entire mouse glial fibrillary acidic protein gene (Gfap) sequences directing expression of Cre recombinase. The construct has a small fragment of the Gfap first exon removed to prevent GFAP expression from the transgene. The transgene was microinjected into fertilized (BALB/c x C57BL/6NHsd)F1 oocytes. Transgenic founders were bred to C57BL/6 mice, and founder line 77.6 was identified. The GFAP-Cre line 77.6 colony was backcrossed onto the C57BL/6 genetic background for at least 15-20 generations. In 2014, Dr. Sofroniew sent female mice to The Jackson Laboratory Repository as Stock No. 024098. Upon arrival, mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish our live colony.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, 4 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
---|---|
Site of Expression | Cre recombinase activity is is observed in most astrocytes throughout the healthy brain and spinal cord and to essentially all astrocytes after Central Nervous System (CNS) injury. Cre recombinase activity is also observed in a subpopulation of the adult stems in the subventricular zone. In contrast to Tg(Gfap-cre)73.12Mvs, there is no targeting of postnatal or adult neural stem cells or their progeny in the hippocampus or other brain regions in Tg(Gfap-cre)77.6Mvs. |
Allele Name | transgene insertion 77.6, Michael V Sofroniew |
---|---|
Allele Type | Transgenic (Recombinase-expressing) |
Allele Synonym(s) | mGFAP-Cre |
Gene Symbol and Name | Tg(Gfap-cre)77.6Mvs, transgene insertion 77.6, Michael V Sofroniew |
Gene Synonym(s) | |
Promoter | Gfap, glial fibrillary acidic protein, mouse, laboratory |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Site of Expression | Cre recombinase activity is is observed in most astrocytes throughout the healthy brain and spinal cord and to essentially all astrocytes after Central Nervous System (CNS) injury. Cre recombinase activity is also observed in a subpopulation of the adult stems in the subventricular zone. In contrast to Tg(Gfap-cre)73.12Mvs, there is no targeting of postnatal or adult neural stem cells or their progeny in the hippocampus or other brain regions in Tg(Gfap-cre)77.6Mvs. |
Strain of Origin | (BALB/c x C57BL/6NHsd)F1 |
Chromosome | UN |
Molecular Note | The bacterial Cre recombinase gene was inserted into the first exon of an expression cassette (clone 445) that contains all the introns, promoter regulatory elements, exons, and 2.5 kb of 5' and 2 kb of 3' flanking DNA of the astroglia-specific mouse glial fibrillary acidic protein gene. GFAP is not expressed from the transgene due to deletion of part of exon 1. Cre expression was detected in a small population of cells within the subependymal zone in the adult brain. No Cre expression or activity was detected during embryonic development or in the hippocampus. |
Mutations Made By | Michael Sofroniew, University of California Los Angeles |
When maintaining a live colony, hemizygous mice may be bred to wildtype (noncarrier) mice from the colony or to C57BL/6J inbred mice (Stock No. 000664).
Of note, the donating investigator reports GFAP-Cre lines 73.12 and 77.6 have cre expression in the male germline, and suggests breeding GFAP-Cre females with floxed males for Cre-lox experiments. See Detailed Description for more details.
When using the GFAP-Cre line 77.6 mouse strain in a publication, please cite the originating article(s) and include JAX stock #024098 in your Materials and Methods section.
Service/Product | Description | Price |
---|---|---|
Hemizyous or Non Carrir for Tg(Gfap-cre)77.6Mvs |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.